India’s Case Fatality Rate (CFR) is 1.45 per cent, whereas globally it is 2.26 per cent, Bhushan avered, adding that India’s CFR is amongst the lowest in the globe. (Representational image AP photo)
Union Health Secretary Rajesh Bhushan on Tuesday stated that adverse events can not be denied when the Covid-19 vaccination drive kicks off in the nation, and added that it is crucial that states and union territories prepare for such possibilities.
Speaking about the preparation for the COVID-19 vaccination drive, Bhushan stated that states have been issued detailed guidelines on handle practices and infection prevention for the duration of the Covid-19 vaccination drive. Also recommendations have been issued concerning the management of minor, serious, really serious adverse events following immunisation, he added.
Talking about the possibilities of adverse events for the duration of the Coronavirus immunisation programme, Bhushan stated that it is a ‘critical aspect’, and stated that in the course of universal immunisation programmes that have been going on for decades, some adverse effects are noticed in kids and pregnant girls right after vaccination.
He cited the instance of the United Kingdom exactly where adverse events have been noticed on the extremely initially day of the Covid-19 vaccine drive, and stated that the possibility of such adverse events could not be denied and it is crucial that the states and union territories be ready for such scenarios.
The execution of the innoculation strategy is going on and states have been offered recommendations for estimation of electrical and non-electrical cold chain gear. Also, recommendations concerning management of cold chain (for storing and safekeeping of temperature-sensitive vaccine vials) and at final cold chain points and session web sites have been issued, the overall health secretary stated.
Giving a lowdown of the quantity of Coronavirus tests held so far in India, Bhushan stated that more than 15.55 crore tests have been carried out so far for detection of coronavirus infection, and the cumulative positivity price has come down to 6.37 whilst the typical day-to-day positivity price for the duration of final week was 3.00 per cent.
India’s Case Fatality Rate (CFR) is 1.45 per cent, whereas globally it is 2.26 per cent, Bhushan averred, adding that India’s CFR is amongst the lowest in the globe.